1. Home
  2. CYCN vs PAVM Comparison

CYCN vs PAVM Comparison

Compare CYCN & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCN
  • PAVM
  • Stock Information
  • Founded
  • CYCN 2018
  • PAVM 2014
  • Country
  • CYCN United States
  • PAVM United States
  • Employees
  • CYCN N/A
  • PAVM N/A
  • Industry
  • CYCN Biotechnology: Pharmaceutical Preparations
  • PAVM Medical/Dental Instruments
  • Sector
  • CYCN Health Care
  • PAVM Health Care
  • Exchange
  • CYCN Nasdaq
  • PAVM Nasdaq
  • Market Cap
  • CYCN 8.4M
  • PAVM 7.2M
  • IPO Year
  • CYCN N/A
  • PAVM 2016
  • Fundamental
  • Price
  • CYCN $4.21
  • PAVM $0.61
  • Analyst Decision
  • CYCN
  • PAVM Strong Buy
  • Analyst Count
  • CYCN 0
  • PAVM 1
  • Target Price
  • CYCN N/A
  • PAVM $19.00
  • AVG Volume (30 Days)
  • CYCN 5.8M
  • PAVM 116.4K
  • Earning Date
  • CYCN 03-04-2025
  • PAVM 03-25-2025
  • Dividend Yield
  • CYCN N/A
  • PAVM N/A
  • EPS Growth
  • CYCN N/A
  • PAVM N/A
  • EPS
  • CYCN N/A
  • PAVM 0.53
  • Revenue
  • CYCN $194,000.00
  • PAVM $4,034,000.00
  • Revenue This Year
  • CYCN N/A
  • PAVM $52.90
  • Revenue Next Year
  • CYCN N/A
  • PAVM $248.84
  • P/E Ratio
  • CYCN N/A
  • PAVM $1.17
  • Revenue Growth
  • CYCN N/A
  • PAVM 166.27
  • 52 Week Low
  • CYCN $1.27
  • PAVM $0.57
  • 52 Week High
  • CYCN $9.47
  • PAVM $3.50
  • Technical
  • Relative Strength Index (RSI)
  • CYCN 58.42
  • PAVM 39.43
  • Support Level
  • CYCN $2.81
  • PAVM $0.62
  • Resistance Level
  • CYCN $6.25
  • PAVM $0.66
  • Average True Range (ATR)
  • CYCN 0.67
  • PAVM 0.05
  • MACD
  • CYCN 0.17
  • PAVM 0.01
  • Stochastic Oscillator
  • CYCN 48.35
  • PAVM 33.52

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

About PAVM PAVmed Inc.

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

Share on Social Networks: